The IL‐6 axis is frequently dysregulated in cancer, which promotes pro‐tumor effects such as cancer growth, migration, and metastasis by activating the IL‐6/JAK/STAT3 pathway.89, 90, 91. Here, STAT3 is linked to neoplasm.